Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Development of new antibiotics is 'stagnant'
Fri June 24th - Work to develop new antibiotics is ‘stagnant’ and does not meet global needs, a new report from the World Health Organization has warned. More
COVID-19 vaccines 'prevented 20 million deaths' in first year
Fri June 24th - In the first year of the vaccination programme, COVID-19 vaccines prevented about 20 million deaths globally, according to an analysis published today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Seaweed plan for antimicrobial therapies

Friday June 9th, 2017

Researchers in the UK hope their studies into alginates – a component in seaweed – could help to tackle multi-drug resistant infections.

A team from Cardiff University’s School of Dentistry have shown how alginates could disrupt the formation of microbial biofilms.

They have used it to develop an inhalation therapy, which is being tested on cystic fibrosis patients, they report.

If trials on the therapy, which helps to clear mucus obstructions in the lungs and potentially slow the progression of the disease, are successful, it could be used in other more common respiratory diseases such as chronic obstructive pulmonary disease.

The studies are also paving the way towards improved treatment of chronic non-healing skin wounds and fighting organisms that cause conditions such as gum disease.

Professor David Thomas, who is leading the research, said: “Our research allowed us to derive material from the natural world with powerful abilities to modify bacterial behaviour, making them more susceptible to antibiotic treatment, and to improve the properties of mucus in patients with lung disease.

“These findings are being applied to the development of alternative treatment approaches for challenging and hard-to-treat diseases.”

The university researchers began working on the project after receiving a small grant from Norwegian biopharmaceutical company AlgiPharma in 2007 for exploratory microbiology studies. It has since developed into a nine-year collaboration between the university’s Advanced Therapies Group (ATG), AlgiPharma and Cardiff & Vale University Health Board.

Phil Rye, research and development director at AlgiPharma, said: “The collaboration has enabled us to make significant advances in the development of a new drug, which is now in human clinical studies, and has recently been included in the US Cystic Fibrosis Foundation drug development pipeline.”

The project is a winning finalist in this year’s Cardiff University’s 2017 Innovation and Impact Awards.

Tags: Respiratory | UK News

Printer friendly page Printer friendly page


1At 01/07/2017 03:36am Annetta wrote

I have been diagnosed with COPD for over 12 years. My principal symptom has been a heavy feeling in the chest. I cannot breathe well while lying flat on my back or on my right side. I have recently had a very major reduction in these symptoms having been prescribed cefdinir for a diagnosis of an upper respiratory viral infection last 4 months. I am only writing this to inform others that nothing was really working to help my condition.I started on Emphysema herbal formula i ordered from Health Herbal Clinic,i read alot of reviews from other previous patients who used the herbal formula, my symptoms totally declined over a 5 weeks use of the COPD natural herbal formula. i am now doing very well, all my symptoms completely faded away, my lungs are totally repaired!! Visit there website www. healthherbalclinic. net or email Info@ healthherbalclinic. net

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)